Analysis of the catalytic site of the actin ADP-ribosylating Clostridium perfringens iota toxin

被引:26
|
作者
vanDamme, J
Jung, M
Hofmann, F
Just, I
Vandekerckhove, J
Aktories, K
机构
[1] UNIV FREIBURG, INST PHARMAKOL & TOXIKOL, D-79104 FREIBURG, GERMANY
[2] STATE UNIV GHENT, FAC MED, DEPT BIOCHEM, INST BIOTECHNOL, B-9000 GHENT, BELGIUM
[3] UNIV SAARLAND, INST PHARMAKOL & TOXIKOL, D-66421 HOMBURG, GERMANY
关键词
D O I
10.1016/0014-5793(96)00052-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme component of the actin ADP-rihosylating Clostridium perfringens iota toxin was affinity labelled by UV irradiation in the presence of [carbonyl-C-14]NAD. A peptide containing the radiolabel was generated by CNBr cleavage and subsequent proteolysis with trypsin, Its amino acid sequence is Gly-Ser-Pro-Gly-Ala-Tyr-Leu-Ser-Ala-Ile-Pro-Gly-Tyr-Ala-G-ly-X-Tyr-Glu-Val-Leu-Leu-Asn-His-Gly-Ser-Lys corresponding with the region Gly-363 through Lys-388 in the C. perfringens iota toxin. Mass spectrometric data as well as the results of the PTH-amino acid analysis are in line with a modification of a glutamic acid side chain located at position 378. Therefore, in addition to Glu-380, as could be concluded by analogy with other ADP-ribosyltransferases, Glu-378 may play a pivotal role in the active site of C. peufringens iota toxin.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 50 条
  • [1] A novel Hsp70 inhibitor prevents cell intoxication with the actin ADP-ribosylating Clostridium perfringens iota toxin
    Katharina Ernst
    Markus Liebscher
    Sebastian Mathea
    Anton Granzhan
    Johannes Schmid
    Michel R. Popoff
    Heiko Ihmels
    Holger Barth
    Cordelia Schiene-Fischer
    Scientific Reports, 6
  • [2] A novel Hsp70 inhibitor prevents cell intoxication with the actin ADP-ribosylating Clostridium perfringens iota toxin
    Ernst, Katharina
    Liebscher, Markus
    Mathea, Sebastian
    Granzhan, Anton
    Schmid, Johannes
    Popoff, Michel R.
    Ihmels, Heiko
    Barth, Holger
    Schiene-Fischer, Cordelia
    SCIENTIFIC REPORTS, 2016, 6
  • [3] Structure function analysis of the actin ADP-ribosylating Clostridium botulinum C2 toxin
    Barth, H
    Preiss, J
    Roebling, R
    Hofmann, F
    Just, I
    Aktories, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R60 - R60
  • [4] Crystal structure of the ADP-ribosylating component of BEC, the binary enterotoxin of Clostridium perfringens
    Kawahara, Kazuki
    Yonogi, Shinya
    Munetomo, Ryota
    Oki, Hiroya
    Yoshida, Takuya
    Kumeda, Yuko
    Matsuda, Shigeaki
    Kodama, Toshio
    Ohkubo, Tadayasu
    Iida, Tetsuya
    Nakamura, Shota
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 480 (02) : 261 - 267
  • [5] Structural basis of actin recognition and ADP-ribosylation by Clostridium perfringens iota-toxin
    Tsuge, Hideaki
    Nagahama, Masahiro
    Oda, Masataka
    Iwamoto, Shinobu
    Utsunomiya, Hiroko
    Marquez, Victor E.
    Katunuma, Nobuhiko
    Nishizawa, Mugio
    Sakurai, Jun
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : C356 - C356
  • [6] ADP-RIBOSYLATION OF ACTIN ISOFORMS BY CLOSTRIDIUM-BOTULINUM-C2 TOXIN AND CLOSTRIDIUM-PERFRINGENS-IOTA TOXIN
    MAUSS, S
    CHAPONNIER, C
    JUST, I
    AKTORIES, K
    GABBIANI, G
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (01): : 237 - 241
  • [7] Substrate specificity of actin-ADP-ribosylation by Clostridium perfringens iota toxin and Clostridium botulinum C2 toxin
    Hochmann, H
    Schleberger, C
    Schulz, GE
    Aktories, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 125 - 126
  • [8] ADP-ribosylating binary toxin genes of Clostridium difficile strain CCUG 20309
    Chang, SY
    Song, KP
    DNA SEQUENCE, 2001, 12 (02): : 115 - 120
  • [9] Uptake of binary actin ADP-ribosylating toxins
    Barth, H
    REVIEWS OF PHYSIOLOGY, BIOCHEMICAL AND PHARMACOLOGY, VOL 152, 2005, 152 : 165 - 182
  • [10] The actin ADP-ribosylating C2 toxin from Clostridium botulinum:: Toxin component interaction in the absence of the cell membrane receptor
    Haug, G
    Hliscs, M
    Aktories, K
    Barth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R121 - R121